Varsha V*, Kavya S T, Sanjay , Kiran Kumar, Vallish Shenoy, Vidyasagar B, Megha Sridhar, Aishwarya Malagi
There is mounting evidence of risk of thrombotic vascular events like stroke, deep vein thrombosis and pulmonary thromboembolism in COVID 19 patients. Risk of stroke increases with advancing age and presence of vascular risk factors. There are cases reported of stroke in young with no known vascular risk factor in COVID 19 patients which is attributed to hypercoagulable state from systemic inflammation, cytokine storm and direct viral induced endothelitis. Biopsy evidence of myocarditis also called as inflammatory cardiomyopathy secondary to SARS-CoV-2 cardio tropism has been recently demonstrated. The two main theories behind are- direct role of ACE2 receptor and a hyper immune response. A final diagnosis of COVID-19 induced myocarditis is seldom made as end myocardial biopsy and cardiac MRI are infrequently done. Hence true incidence of myocarditis in COVID-19 is likely to be higher. Here we are presenting a case report of 26 year old female with two uncommon complications of COVID 19 infection.